9,10-dimethyl-1,2-benzanthracene has been researched along with tmk 688 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, H; Kato, R; Yamamoto, S | 1 |
| Jiang, H; Kato, R; Ozawa, S; Shimada, M; Yamamoto, S; Yamazoe, Y | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and tmk 688
| Article | Year |
|---|---|
Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Administration, Topical; Animals; Anticarcinogenic Agents; Arachidonate Lipoxygenases; Benzo(a)pyrene; Female; Indomethacin; Lipoxygenase Inhibitors; Mice; Mice, Inbred Strains; Piperidines; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1994 |
Inhibitory effect of TMK688 on skin tumor initiation caused by 7,12-dimethylbenz[a]anthracene in relation to inhibition of aryl hydrocarbon hydroxylase activity and Cyp1a1 mRNA induction.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aryl Hydrocarbon Hydroxylases; Base Sequence; Benzo(a)pyrene; Carcinogens; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Enzyme Induction; Epidermis; Female; Gene Expression Regulation, Enzymologic; Lipoxygenase Inhibitors; Mice; Piperidines; RNA, Messenger; Skin Neoplasms | 1996 |